Literature DB >> 20655790

Plasmodium vivax and the Duffy antigen: a paradigm revisited.

O Mercereau-Puijalon1, D Ménard.   

Abstract

The Duffy blood group antigen is the portal of entry of the Plasmodiumvivax malaria parasite into human red blood cells and the receptor for a number of CXC and CC chemokines. We review here epidemiological data and evidence derived from therapeutic or experimental human infections associating P. vivax and the Duffy glycoprotein and laboratory studies indicating that P. vivax uses the Duffy antigen as a receptor to invade the red cell. We then review recent field observations indicating that the conclusion of the absolute dependence on the presence of Duffy on the red cell for P. vivax infection and development into the red cell no longer holds true and that in some parts of the world, P. vivax infects and causes disease in Duffy-negative people. Copyright 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20655790     DOI: 10.1016/j.tracli.2010.06.005

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


  15 in total

Review 1.  Molecular basis of the Duffy blood group system.

Authors:  Gabriela Höher; Marilu Fiegenbaum; Silvana Almeida
Journal:  Blood Transfus       Date:  2017-01-30       Impact factor: 3.443

2.  Diversity, host switching and evolution of Plasmodium vivax infecting African great apes.

Authors:  Franck Prugnolle; Virginie Rougeron; Pierre Becquart; Antoine Berry; Boris Makanga; Nil Rahola; Céline Arnathau; Barthélémy Ngoubangoye; Sandie Menard; Eric Willaume; Francisco J Ayala; Didier Fontenille; Benjamin Ollomo; Patrick Durand; Christophe Paupy; François Renaud
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-01       Impact factor: 11.205

3.  A long neglected world malaria map: Plasmodium vivax endemicity in 2010.

Authors:  Peter W Gething; Iqbal R F Elyazar; Catherine L Moyes; David L Smith; Katherine E Battle; Carlos A Guerra; Anand P Patil; Andrew J Tatem; Rosalind E Howes; Monica F Myers; Dylan B George; Peter Horby; Heiman F L Wertheim; Ric N Price; Ivo Müeller; J Kevin Baird; Simon I Hay
Journal:  PLoS Negl Trop Dis       Date:  2012-09-06

4.  Targeting wild-type Erythrocyte receptors for Plasmodium falciparum and vivax Merozoites by Zinc Finger Nucleases In- silico: Towards a Genetic Vaccine against Malaria.

Authors:  Henry Kajumbula; Wilson Byarugaba; Misaki Wayengera
Journal:  Genet Vaccines Ther       Date:  2012-08-31

Review 5.  The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria.

Authors:  Quique Bassat
Journal:  PLoS Negl Trop Dis       Date:  2011-12-27

6.  Vivax malaria in Mauritania includes infection of a Duffy-negative individual.

Authors:  Nathalie Wurtz; Khadijetou Mint Lekweiry; Hervé Bogreau; Bruno Pradines; Christophe Rogier; Ali Ould Mohamed Salem Boukhary; Jamal Eddine Hafid; Mohamed Salem Ould Ahmedou Salem; Jean-François Trape; Leonardo K Basco; Sébastien Briolant
Journal:  Malar J       Date:  2011-11-03       Impact factor: 2.979

7.  Studies of a murine monoclonal antibody directed against DARC: reappraisal of its specificity.

Authors:  Dorota Smolarek; Claude Hattab; Anna Buczkowska; Radoslaw Kaczmarek; Anna Jarząb; Sylvie Cochet; Alexandre G de Brevern; Jolanta Lukasiewicz; Wojciech Jachymek; Tomasz Niedziela; Magdalena Grodecka; Kazimiera Wasniowska; Yves Colin Aronovicz; Olivier Bertrand; Marcin Czerwinski
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

Review 8.  Resistance to malaria in humans: the impact of strong, recent selection.

Authors:  Philip W Hedrick
Journal:  Malar J       Date:  2012-10-22       Impact factor: 2.979

Review 9.  Online biomedical resources for malaria-related red cell disorders.

Authors:  Frédéric B Piel; Rosalind E Howes; Oscar A Nyangiri; Catherine L Moyes; Thomas N Williams; David J Weatherall; Simon I Hay
Journal:  Hum Mutat       Date:  2013-05-08       Impact factor: 4.878

10.  Plasmodium vivax infection in Anajás, State of Pará: no differential resistance profile among Duffy-negative and Duffy-positive individuals.

Authors:  Tarcisio A A Carvalho; Maíse G Queiroz; Greice L Cardoso; Isabela G Diniz; Aylla N L M Silva; Ana Y N Pinto; João F Guerreiro
Journal:  Malar J       Date:  2012-12-22       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.